Sage Mountain Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Sage Mountain Advisors's LLY Position: Q1 2026 in Review
Sage Mountain Advisors reduced its Eli Lilly (LLY) stake by 85% in Q1 2026, selling an estimated $6.13M and leaving 1,086 shares worth $999K. The position accounts for 0.07% of the portfolio, ranked #92.
Sage Mountain Advisors first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $7.66M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sage Mountain Advisors held 1,086 shares of Eli Lilly worth $999K as of Q1 2026.
- Sage Mountain Advisors sold 6,046 Eli Lilly shares in Q1 2026, an estimated $6.13M.
- Eli Lilly made up 0.07% of Sage Mountain Advisors's portfolio in Q1 2026, its #92 holding.
- Sage Mountain Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- Sage Mountain Advisors's Eli Lilly position peaked at $7.66M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.